Table 1.
Adolescent demographic characteristics at last viral load.
| Nb | All N = 10 096 | Suppressed N = 7413 (73%) | Unsuppressed N = 2683 (27%) | |
|---|---|---|---|---|
| Adolescent characteristic | n (%) or median (IQR)c | n (%) or median (IQR)d | n (%) or median (IQR)d | |
| Age-group | 10 096 | |||
| 10–14 | 3399 (34%) | 2284 (67%) | 1115 (33%) | |
| 15–19 | 2316 (23%) | 1572 (68%) | 744 (32%) | |
| 20–24 | 4381 (43%) | 3557 (81%) | 824 (19%) | |
| Sex | 10 060 | |||
| Male | 3050 (30%) | 1993 (65%) | 1057 (35%) | |
| Female | 7010 (70%) | 5391 (77%) | 1619 (23%) | |
| Mode of infection | 10 096 | |||
| Perinatal | 4341 (43%) | 2886 (66%) | 1455 (34%) | |
| Horizontal | 5755 (57%) | 4527 (79%) | 1228 (21%) | |
| ART regimen | 10 046 | |||
| NNRTI | 9033 (90%) | 6644 (74%) | 2389 (26%) | |
| PI | 898 (9%) | 642 (71%) | 256 (29%) | |
| Othera | 115 (1%) | 86 (75%) | 29 (25%) | |
| ART duration | 10 096 | |||
| 6 months to 1 year | 1603 (16%) | 1301 (81%) | 302 (19%) | |
| 1–2 years | 1,977 (20%) | 1567 (79%) | 410 (21%) | |
| 2–5 years | 3275 (32%) | 2388 (73%) | 887 (27%) | |
| 5–10 years | 2698 (27%) | 1781 (66%) | 917 (34%) | |
| Over 10 years | 543 (5%) | 376 (69%) | 167 (31%) | |
| Turn-around time | 10 067 | 12 (7–20) | 12 (7–19) | 12 (7–21) |
IQR, interquartile range; NNRTI, nonnucleoside reverse transcriptase inhibitor.
a
Integrase inhibitor, triple nucleotide, unspecified.
b
Data on sex, antiretroviral therapy (ART) regimen and turnaround time not available for all adolescents and young adults.
c
Column (%).
d
Row (%).